To view this site, you need to have JavaScript enabled in your browser, and either the Flash Plugin or an HTML5-Video enabled browser. Download the latest Flash player and try again.

Inside Teva's CEO Transition

Tuesday, 10 Jan 2012 | 3:15 PM ET

William Marth, Teva Americas President & CEO, discusses the company's leadership shuffle, what it's doing to fend off generic competition from Indian upstarts and lackluster generic drugs sales in the U.S.